WeVote

Bill

Bill

HR 5483

Chloe Cole Act

119th Congress Introduced by Robert Aderholt and 34 co-sponsors

The Chloe Cole Act ensures minors receive gender-affirming treatments only with informed consent from parents, mental health evaluations, and age restrictions for safety.

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 5483

Summary of HR 5483 - Chloe Cole Act

Introduction

The Chloe Cole Act (HR 5483) was introduced in the House of Representatives on September 18, 2025. The bill aims to address specific issues related to healthcare and patient rights, particularly concerning minors and gender-affirming medical treatments.

Purpose and Intent

The primary purpose of the Chloe Cole Act is to establish regulations and guidelines surrounding the provision of gender-affirming treatments to minors. The bill seeks to ensure that minors receive appropriate care that considers their long-term health and well-being, emphasizing informed consent and parental involvement in medical decisions.

Key Provisions

While the full text of the bill is not provided, the following key provisions can be anticipated based on the bill's title and legislative context:

  • Informed Consent: The bill may require healthcare providers to obtain informed consent from both the minor and their parents or guardians before administering any gender-affirming treatments.

  • Age Restrictions: It could establish specific age limits for when minors may receive certain medical interventions, ensuring that treatments are only provided to those who meet established criteria.

  • Mental Health Evaluations: The legislation may mandate comprehensive mental health evaluations prior to any medical intervention, ensuring that minors are fully assessed for their mental and emotional readiness.

  • Reporting Requirements: Healthcare providers might be required to report data on the number of procedures performed on minors, including outcomes and any adverse effects.

Affected Parties

The Chloe Cole Act would primarily affect:

  • Minors seeking gender-affirming treatments: The bill aims to protect their rights while ensuring they receive appropriate care.

  • Parents and guardians: The legislation emphasizes their role in the decision-making process regarding their children's healthcare.

  • Healthcare providers: Medical professionals would need to comply with new regulations and guidelines established by the bill.

Legislative Actions

  • Introduced: September 18, 2025
  • Referred to Committee: The bill has been referred to the House Committee on Energy and Commerce for further consideration.

Sponsors

The Chloe Cole Act is sponsored by a group of cosponsors, including:

  • Brandon Gill
  • Mike Collins
  • Harriet M. Hageman
  • Robert B. Aderholt
  • Sheri Biggs
  • Richard McCormick
  • Glenn Grothman
  • Andrew Ogles
  • Pat Harrigan
  • Charles J. "Chuck" Fleischmann
  • Josh Brecheen
  • Dan Crenshaw
  • James R. Baird
  • Andy Harris
  • Earl L. "Buddy" Carter
  • John W. Rose
  • Barry Moore
  • Gregory F. Murphy
  • Michael K. Simpson

Conclusion

The Chloe Cole Act represents a significant legislative effort to regulate gender-affirming treatments for minors, focusing on informed consent and parental involvement. As the bill progresses through the legislative process, further details will emerge regarding its specific provisions and implications for healthcare practices.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.